Obligations de 0TDF
Voici la liste des obligations d'entreprise de ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS . Les investisseurs optent souvent pour les obligations d'une société en raison de leur stabilité accrue en période de volatilité du marché. Étudiez les prix, les rendements et d'autres statistiques et trouvez un investissement fiable.
Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
|---|---|---|---|---|---|---|---|---|---|
| CCHGCY5317644Roche Holdings, Inc. 2.607% 13-DEC-2051 | 6,58% | 3,5 M | 61,30% | 2,61% | 2051-12-13 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| UUSU75000BT2ROCHE HLDGS 22/25 REGS | 6,13% | 0 | 99,14% | 2,13% | 2025-03-10 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY4184535Roche Holdings, Inc. 4.0% 28-NOV-2044 | 5,82% | 1,2 M | 83,20% | 4,00% | 2044-11-28 | 650 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766485Roche Holdings, Inc. 5.218% 08-MAR-2054 | 5,36% | 5 M | 98,33% | 5,22% | 2054-03-08 | 1,6 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5317198Roche Holdings, Inc. 2.076% 13-DEC-2031 | 5,28% | 250 K | 83,67% | 2,08% | 2031-12-13 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY3666852Genentech, Inc. 5.25% 15-JUL-2035 | 5,20% | 2 M | 100,36% | 5,25% | 2035-07-15 | 288,45 M USD | 1 000,00 USD | 1 000,00 USD | Genentech, Inc. |
| CCHGCY5766483Roche Holdings, Inc. 4.985% 08-MAR-2034 | 5,19% | 4,26 M | 98,70% | 4,99% | 2034-03-08 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766486Roche Holdings, Inc. 5.218% 08-MAR-2054 | 5,13% | 5 M | 101,00% | 5,22% | 2054-03-08 | 1,6 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| UUSU75000BL9ROCHE HLDGS 16/27 REGS | 5,11% | 0 | 94,80% | 2,38% | 2027-01-28 | 850 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766481Roche Holdings, Inc. 4.909% 08-MAR-2031 | 5,09% | 8 M | 99,09% | 4,91% | 2031-03-08 | 750 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| UUSU75000BP0ROCHE HLDGS 18/28 REGS | 5,00% | 0 | 95,67% | 3,63% | 2028-09-17 | 650 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766479Roche Holdings, Inc. 4.79% 08-MAR-2029 | 4,97% | 1,8 M | 99,31% | 4,79% | 2029-03-08 | 875,2 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5317643Roche Holdings, Inc. 1.93% 13-DEC-2028 | 4,95% | 400 K | 89,94% | 1,93% | 2028-12-13 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766484Roche Holdings, Inc. 4.985% 08-MAR-2034 | 4,94% | 2,33 M | 100,30% | 4,99% | 2034-03-08 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885614Roche Holdings, Inc. 5.218% 08-MAR-2054 | 4,90% | 800 K | 103,80% | 5,22% | 2054-03-08 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698748Roche Holdings, Inc. 5.593% 13-NOV-2033 | 4,87% | 250 K | 104,48% | 5,59% | 2033-11-13 | 1,6 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| RRH0HROCHE HLDGS 16/26 REGS | 4,85% | 0 | 97,08% | 2,63% | 2026-05-15 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5373738Roche Holdings, Inc. FRN 10-MAR-2025 | 4,85% | 2 M | 100,09% | 5,17% | 2025-03-10 | 750 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885612Roche Holdings, Inc. 4.592% 09-SEP-2034 | 4,81% | 1,52 M | 98,54% | 4,59% | 2034-09-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698672Roche Holdings, Inc. FRN 13-NOV-2026 | 4,80% | 9,54 M | 100,98% | 5,34% | 2026-11-13 | 300 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| UUSU75000BV7ROCHE HLDGS 22/27 REGS | 4,79% | 0 | 95,03% | 2,31% | 2027-03-10 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766480Roche Holdings, Inc. 4.79% 08-MAR-2029 | 4,76% | 1,4 M | 100,11% | 4,79% | 2029-03-08 | 875,2 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5766482Roche Holdings, Inc. 4.909% 08-MAR-2031 | 4,66% | 200 K | 101,20% | 4,91% | 2031-03-08 | 750 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885610Roche Holdings, Inc. 4.203% 09-SEP-2029 | 4,66% | 200 K | 98,23% | 4,20% | 2029-09-09 | 900 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698943Roche Holdings, Inc. 5.489% 13-NOV-2030 | 4,63% | 50 K | 103,96% | 5,49% | 2030-11-13 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY4391962Roche Holdings, Inc. 7.0% 01-MAR-2039 | 4,63% | 15 K | 120,31% | 7,00% | 2039-03-01 | 1,12 B USD | 1 000,00 USD | 2 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698942Roche Holdings, Inc. 5.338% 13-NOV-2028 | 4,54% | 200 K | 102,65% | 5,34% | 2028-11-13 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5698948Roche Holdings, Inc. 5.265% 13-NOV-2026 | 4,53% | 400 K | 101,29% | 5,27% | 2026-11-13 | 1,1 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY4307677Roche Holdings, Inc. 3.0% 10-NOV-2025 | 4,51% | 200 K | 98,70% | 3,00% | 2025-11-10 | 506,05 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5141501Roche Holdings, Inc. 0.991% 05-MAR-2026 | 4,35% | 500 K | 96,02% | 0,99% | 2026-03-05 | 650 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| XXS281321161ROCHE F. EUR 24/44 MTN | 3,41% | 0 | 101,79% | 3,56% | 2044-05-03 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | Roche Finance Europe BV |
| XXS272633509ROCHE F. EUR 23/36 MTN | 3,24% | 0 | 103,02% | 3,59% | 2036-12-04 | 900 M EUR | 1 000,00 EUR | 100 000,00 EUR | Roche Finance Europe BV |
| XXS259208840ROCHE F. EUR 23/35 MTN | 3,06% | 0 | 102,27% | 3,36% | 2035-02-27 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Roche Finance Europe BV |
| XXS281321129ROCHE F. EUR 24/30 MTN | 2,66% | 0 | 102,67% | 3,23% | 2030-05-03 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | Roche Finance Europe BV |
| XXS259208823ROCHE F. EUR 23/29 MTN | 2,63% | 0 | 102,42% | 3,20% | 2029-08-27 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Roche Finance Europe BV |
| XXS119505607ROCHE FIN.EUROPE 15/25MTN | 2,58% | 0 | 99,69% | 0,88% | 2025-02-25 | 1 B EUR | 1 000,00 EUR | 1 000,00 EUR | Roche Finance Europe BV |
| XXS272633193ROCHE F. EUR 23/27 MTN | 2,54% | 0 | 102,11% | 3,31% | 2027-12-04 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Roche Finance Europe BV |
| CCH137173682ROCHE KAPIT. 24/39 | 0,96% | 0 | 102,71% | 1,17% | 2039-09-06 | 275 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3K2NXROCHE KAPITALMARKT AG 2022-25.02.37 GUARANTEED REG S | 0,92% | 0 | 100,88% | 1,00% | 2037-02-25 | 300 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3LRKJROCHE KAPITALMARKT AG 2023-15.09.38 | 0,86% | 0 | 113,41% | 1,95% | 2038-09-15 | 230 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| CCH137173681ROCHE KAPIT. 24/34 | 0,82% | 0 | 102,50% | 1,10% | 2034-09-06 | 420 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3LRKKROCHE KAPITALMARKT AG 2023-15.09.33 | 0,77% | 0 | 107,99% | 1,75% | 2033-09-15 | 190 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3K88AROCHE KAPITALMARKT AG 2022-23.09.32 GUARANTEED | 0,75% | 0 | 109,18% | 2,00% | 2032-09-23 | 375 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3K2RBROCHE KAPITALMARKT AG 2022-25.02.31 GUARANTEED REG S | 0,70% | 0 | 100,28% | 0,75% | 2031-02-25 | 625 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| CCH137173680ROCHE KAPIT. 24/29 | 0,69% | 0 | 101,35% | 0,99% | 2029-09-06 | 250 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3K88BROCHE KAPITALMARKT AG 2022-23.06.26 GUARANTEED | 0,68% | 0 | 101,23% | 1,50% | 2026-06-23 | 425 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| CCH43376131ROCHE KAPITALMKT 18-30 | 0,66% | 0 | 100,52% | 0,75% | 2030-09-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| CCH35991540ROCHE KAPITALMKT 17-29 | 0,64% | 0 | 99,20% | 0,45% | 2029-03-23 | 350 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3LQ44ROCHE KAPITALMARKT AG 2023-15.09.28 | 0,55% | 0 | 103,83% | 1,60% | 2028-09-15 | 140 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| AA3K2JZROCHE KAPITALMARKT AG 2022-25.02.27 GUARANTEED REG S | 0,55% | 0 | 99,90% | 0,50% | 2027-02-25 | 825 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| CCH43376130ROCHE KAPITALMKT 18-25 | 0,42% | 0 | 99,87% | 0,25% | 2025-09-24 | 500 M CHF | 5 000,00 CHF | 5 000,00 CHF | Roche Kapitalmarkt AG |
| CCHGCY5885609Roche Holdings, Inc. 4.203% 09-SEP-2029 | — | — | — | 4,20% | 2029-09-09 | 900 M USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |
| CCHGCY5885611Roche Holdings, Inc. 4.592% 09-SEP-2034 | — | — | — | 4,59% | 2034-09-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Roche Holdings, Inc. |